Evidence map›Paper›PMID 37520459›Full record

ArticleHealth science reports2023

Initiating the first rheumatic heart disease clinic in Cameroon: A descriptive study.

Nelson Njedock, Nathan Yanwou, Maxime Wotol, Beckly Shu, Raisa Azanfack, Clovis Nkoke, David Chelo

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nelson NjedockFaculty of Medicine and Biomedical Sciences University of Yaoundé 1 Yaoundé Cameroon.ORCID 0000-0003-3300-158X
Nathan YanwouFaculty of Medicine and Biomedical Sciences University of Yaoundé 1 Yaoundé Cameroon.
Maxime WotolFriendly Heart Yaounde Cameroon.
Beckly ShuFaculty of Medicine and Biomedical Sciences University of Yaoundé 1 Yaoundé Cameroon.
Raisa AzanfackFriendly Heart Yaounde Cameroon.
Clovis NkokeFaculty of Health Sciences University of Buea Buea Cameroon.
David CheloFaculty of Medicine and Biomedical Sciences University of Yaoundé 1 Yaoundé Cameroon.
Université de Yaoundé I · CMUniversity of Buea · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Rheumatic heart disease (RHD) is a significant cause of heart failure in sub-Saharan Africa. The causes of death from RHD are multiple, many of which can be prevented with appropriate follow-up of patients and effective secondary prophylaxis. An RHD Clinic was initiated to attempt a solution in Yaoundé, Cameroon. Over 6 months, its impact was evaluated. Methods: Two echocardiography registers were accessed, and patients diagnosed with RHD between 2005 and 2018 were contacted. Consenting carers and patients pioneered the first RHD Clinic. Activities of the clinic comprised health education, medical visits, and benzylpenicillin G (BPG) injections. Text messages and phone calls were used to remind patients of their monthly appointments. Results: Out of 1200 first-time cardiac ethnographies, 70 patients (5.83%) had been diagnosed with RHD. The case fatality rate of RHD was 16.67%. Twenty-three patients were successfully registered and followed-up by the clinic, 70% of whom were female. The age range was 4-22 years. Fifty-three percent had an NYHA score of 2 or more at the time of admission into the clinic. There was an increase in adherence to secondary prophylaxis with BPG from 42.9% at baseline to 87%-95% in the last 3 months. Conclusion: Our short experience running an RHD Clinic was marked by increased treatment adherence among persons living with RHC.

Indexed as

cameroonchildrenhealthcare servicesrheumatic heart diseasetext messages

Identifiers

PMID37520459
PMCPMC10375454
OpenAlexW4385343884

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.